Promising immunotherapy for prostate cancer. - Wikidata - wikimedia - TriplyDB

Promising immunotherapy for prostate cancer.

Promising immunotherapy for prostate cancer.

http://www.wikidata.org/entity/Q47566793

about

Promising immunotherapy for prostate cancer.

http://www.wikidata.org/entity/Q47566793

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Promising immunotherapy for prostate cancer.

@en

Promising immunotherapy for prostate cancer.

@nl

type

label

Promising immunotherapy for prostate cancer.

@en

Promising immunotherapy for prostate cancer.

@nl

prefLabel

Promising immunotherapy for prostate cancer.

@en

Promising immunotherapy for prostate cancer.

@nl

P1433

Q47566793-6FCC4B3F-4389-4D19-9A6B-18DF1B725A67

P1476

Q47566793-D4D24F63-4748-463E-9589-7ACB356BB512

P2093

Q47566793-2EDD412F-ACC9-44B7-B0BD-41059922E97F

Q47566793-F58E65D8-19E1-4E09-BA95-738783DC3D63

P2860

Q47566793-015A8B81-4B38-4CE0-9D92-06A6EBEC09AB

Q47566793-028445C3-31A1-432F-880C-EADE26BD965C

Q47566793-039D81CA-78C8-4BE7-A5E2-0C4E257FAA42

Q47566793-05B03B3B-6EFA-44F8-B5E8-9949F99FBE5C

Q47566793-088AA0A7-9A8A-4D4E-9744-79FC24F7A30A

Q47566793-16995204-1767-44CF-8785-4ACF7DCF2C5F

Q47566793-1B451434-EEAF-436C-8E41-837F7EE948E9

Q47566793-1BCA2819-F153-48B4-A80E-1DA2E5B8A38D

Q47566793-1F2374A7-6842-4CD9-BD73-CD5BBA7B710E

Q47566793-1F9E37CC-81DE-4BD2-B863-BC18686D6865

P304

Q47566793-3A604E88-021B-4196-B26C-F5436F8DD832

P31

Q47566793-CF36DC6D-A601-48FA-BE81-B728CC7140E8

Q47566793-b81a87bf-bca0-463a-ab10-69a70786b16f

P356

Q47566793-79A0C3F6-7B6C-4578-9B04-7E728194CB07

P407

Q47566793-7ADBDD2E-7A8F-4387-90A7-94A8A47C6842

P433

Q47566793-3DD1ECCD-F240-42B7-A73E-E2A9EEC8F510

P478

Q47566793-4F3AC577-5AE7-421E-9227-FB09F957C884

P577

Q47566793-F9887DDC-4B1E-4FDD-9A53-C2B6466EE513

P698

Q47566793-00E3A5FE-966B-424D-BED2-73DEA65FFA83

P921

Q47566793-A500513F-97D9-4841-98C3-3D1380FD29B3

P356

14712598.2018.1406916

P1433

Expert Opinion on Biological Therapy

P1476

Promising immunotherapy for prostate cancer.

@en

P2093

Guru Sonpavde

http://www.w3.org/2001/XMLSchema#string

John C Henegan

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of allogeneic fetal rejection by tryptophan catabolism

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Abiraterone in metastatic prostate cancer without previous chemotherapy

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer

High expression of a specific T-cell receptor gamma transcript in epithelial cells of the prostate

Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline.

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

P304

109-120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14712598.2018.1406916

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29231062

http://www.w3.org/2001/XMLSchema#string

P921